Ikena Oncology Inc
NASDAQ:IKNA
Ikena Oncology Inc
NASDAQ:IKNA
Price:
17.16
USD
4.38%
Market Cap:
$2.1B
Income Statement
Earnings Waterfall
Ikena Oncology Inc
Ikena Oncology Inc
Income Statement
Ikena Oncology Inc
Ikena Oncology Inc
Currency: USD
| Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Revenue |
7
N/A
|
7
+7%
|
11
+53%
|
31
+186%
|
31
0%
|
28
-10%
|
30
+10%
|
16
-49%
|
18
+12%
|
19
+9%
|
14
-27%
|
9
-34%
|
4
-58%
|
2
-52%
|
1
-64%
|
0
N/A
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(47)
|
(56)
|
(74)
|
(65)
|
(72)
|
(77)
|
(83)
|
(87)
|
(87)
|
(86)
|
(83)
|
(85)
|
(79)
|
(74)
|
(65)
|
(55)
|
|
| Selling, General & Administrative |
(8)
|
(11)
|
(16)
|
(18)
|
(21)
|
(22)
|
(22)
|
(22)
|
(21)
|
(21)
|
(22)
|
(25)
|
(26)
|
(26)
|
(24)
|
(24)
|
|
| Research & Development |
(40)
|
(45)
|
(58)
|
(47)
|
(51)
|
(56)
|
(61)
|
(64)
|
(66)
|
(65)
|
(61)
|
(60)
|
(54)
|
(48)
|
(41)
|
(31)
|
|
| Operating Income |
(41)
N/A
|
(48)
-19%
|
(63)
-30%
|
(34)
+46%
|
(41)
-21%
|
(50)
-20%
|
(53)
-7%
|
(71)
-34%
|
(69)
+2%
|
(67)
+4%
|
(69)
-2%
|
(75)
-10%
|
(76)
0%
|
(72)
+4%
|
(64)
+11%
|
(55)
+15%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
4
|
5
|
7
|
8
|
8
|
8
|
7
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(3)
|
(4)
|
(4)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
1
|
1
|
1
|
(0)
|
(0)
|
0
|
1
|
3
|
|
| Pre-Tax Income |
(41)
N/A
|
(48)
-19%
|
(63)
-30%
|
(34)
+46%
|
(41)
-21%
|
(49)
-19%
|
(52)
-6%
|
(69)
-33%
|
(66)
+4%
|
(63)
+5%
|
(63)
N/A
|
(68)
-9%
|
(70)
-3%
|
(67)
+5%
|
(60)
+11%
|
(49)
+18%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Income from Continuing Operations |
(41)
|
(48)
|
(63)
|
(34)
|
(41)
|
(49)
|
(52)
|
(69)
|
(66)
|
(63)
|
(63)
|
(68)
|
(70)
|
(67)
|
(60)
|
(49)
|
|
| Net Income (Common) |
(41)
N/A
|
(48)
-19%
|
(63)
-30%
|
(34)
+46%
|
(41)
-21%
|
(49)
-19%
|
(52)
-6%
|
(69)
-33%
|
(66)
+4%
|
(63)
+5%
|
(63)
N/A
|
(68)
-9%
|
(70)
-3%
|
(67)
+5%
|
(60)
+11%
|
(49)
+17%
|
|
| EPS (Diluted) |
-1.13
N/A
|
-1.37
-21%
|
-1.77
-29%
|
-0.95
+46%
|
-1.14
-20%
|
-1.36
-19%
|
-1.44
-6%
|
-1.9
-32%
|
-1.83
+4%
|
-1.59
+13%
|
-1.44
+9%
|
-1.63
-13%
|
-1.45
+11%
|
-1.38
+5%
|
-1.24
+10%
|
-1.02
+18%
|
|
Switch to:
Switch to:
See Also
Discover More
